The trial had been closely watched because the defendants were the first Chinese companies to face civil price-fixing claims on U.S. soil, and because they tried to escape liability by arguing that they simply followed orders from their government.
March 18, 2013 at 12:00 AM
1 minute read
After a historic jury trial, two Chinese companiesHebei Welcome Pharmaceutical Company Ltd. and North China Pharmaceutical Group Corp.have been ordered to pay $162 million for fixing Vitamin C prices.
A federal jury in Brooklyn returned a $54 million verdict against the defendants on March 14. Eastern District Judge Brian Cogan (See Profile) awarded trebled damages to $162 million.
Deal Watch: Skadden, Sidley, Slaughter and S&C Lead Big Paper Deal, While Private Funds Grow Massive
Presented by BigVoodoo
The New York Law Journal honors attorneys and judges who have made a remarkable difference in the legal profession in New York.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
